Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects

Sohee Son, Sung Mook Lim, Su Young Chae, Kwang Meyung Kim, Eun Ji Park, Kang Choon Lee, Dong Hee Na

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hydrophobically modified glycol chitosan (HGC) nanoparticles loaded with mono-lithocholic acid-conjugated exendin-4 at the Lys27 residue (LAM1-Ex4) were prepared and characterized by particle size measurement, proteolytic stability, in vitro drug-release profile, and in vivo antidiabetic effects in a db/db diabetic mouse model. Compared with Ex-4-loaded HGC nanoparticles (Ex4/HGC NPs) prepared as a control, LAM1-Ex4-loaded HGC nanoparticles (LAM1-Ex4/HGC NPs) showed improved drug-loading efficiency, small particle size, enhanced resistance against proteolytic digestion, and an extended in vitro drug release profile. These findings may be attributable to the strong hydrophobic interaction between LAM1-Ex4 and the inner core of HGC. Furthermore, LAM1-Ex4/HGC NPs showed prolonged hypoglycemic efficacy in db/db mice, lasting 1 week after a single subcutaneous administration. The present study demonstrated that LAM1-Ex4/HGC NPs have considerable potential as a long-acting sustained-release antidiabetic system for type 2 diabetes.

Original languageEnglish
Pages (from-to)81-86
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume495
Issue number1
DOIs
Publication statusPublished - 2015 Nov 10
Externally publishedYes

Keywords

  • Antidiabetic effects
  • Exendin-4
  • Glycol chitosan
  • Lithocholic acid
  • Nanoparticles

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects'. Together they form a unique fingerprint.

  • Cite this